Can a combination of vaccination and face mask wearing contain the COVID-19 pandemic?
Journal
Microbial biotechnology
ISSN: 1751-7915
Titre abrégé: Microb Biotechnol
Pays: United States
ID NLM: 101316335
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
11
12
2021
accepted:
16
12
2021
pubmed:
29
12
2021
medline:
18
3
2022
entrez:
28
12
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic is going into its third year with Europe again being the focus of major epidemic activity. The present review tries to answer the question whether one can come to grip with the pandemic by a combination of vaccinations and non-pharmaceutical interventions (NPIs). Several COVID-19 vaccines are of remarkable efficacy and achieve high protection rates against symptomatic disease, especially severe disease, but mathematical models suggest that the current vaccination coverage in many countries is insufficient to achieve pandemic control. NPIs are needed as complementary measures because recent research has also revealed the limits of vaccination alone. Here, we review the evidence for efficacy of face mask wearing in various settings. Overall pooled analysis showed significant reduction in COVID-19 incidence with mask wearing, although heterogeneity between studies was substantial. Controlled trials of mask wearing are difficult to conduct, separating mask wearing effects in population studies from the impact of other NPIs is challenging and the efficacy of masks depend on mask material and mask fit. The combination of vaccination and mask wearing is potentially synergistic since vaccination protects so far well from disease development (the omicron variant is currently an unknown) but immunity from infection wanes over few months after vaccination. In comparison, masks interfere with the virus transmission process at a level of a physical barrier independent of coronavirus variant. Vaccination and masks are much less costly to apply than other NPI measures which are associated with high economic and social costs, but paradoxically both measures are the target of a vocal opposition by a sizable minority of the society. In parallel with biomedical research, we need more social science research into this opposition to guide political decisions on how to end the pandemic.
Identifiants
pubmed: 34962710
doi: 10.1111/1751-7915.13997
pmc: PMC8913850
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
721-737Informations de copyright
© 2021 The Authors. Microbial Biotechnology published by Society for Applied Microbiology and John Wiley & Sons Ltd.
Références
Nature. 2021 Oct;598(7881):398-399
pubmed: 34650240
JAMA Netw Open. 2021 Nov 1;4(11):e2132540
pubmed: 34726743
Nature. 2020 Jul;583(7814):155-156
pubmed: 32601491
N Engl J Med. 2021 Jul 22;385(4):320-329
pubmed: 34192428
N Engl J Med. 2021 Dec 9;385(24):e83
pubmed: 34614327
Microb Biotechnol. 2021 Nov;14(6):2244-2253
pubmed: 34464023
Trials. 2021 Nov 7;22(1):780
pubmed: 34743755
Microb Biotechnol. 2021 Sep;14(5):1860-1870
pubmed: 34254725
Lancet Respir Med. 2020 May;8(5):434-436
pubmed: 32203710
N Engl J Med. 2021 Aug 19;385(8):759-760
pubmed: 34161702
Nat Med. 2021 Aug;27(8):1370-1378
pubmed: 34108716
Science. 2021 Feb 19;371(6531):
pubmed: 33323424
Science. 2022 Jan 14;375(6577):eabi9069
pubmed: 34855513
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
JAMA Netw Open. 2021 Oct 1;4(10):e2130800
pubmed: 34714342
Am J Trop Med Hyg. 2020 Dec;103(6):2400-2411
pubmed: 33124541
BMJ. 2020 Apr 9;369:m1435
pubmed: 32273267
Lancet Digit Health. 2021 Mar;3(3):e148-e157
pubmed: 33483277
Lancet Infect Dis. 2022 Feb;22(2):183-195
pubmed: 34756186
Nat Commun. 2021 Oct 28;12(1):6220
pubmed: 34711813
Science. 2021 Dec 17;374(6574):eabl9551
pubmed: 34726481
Med (N Y). 2021 Aug 13;2(8):979-992.e8
pubmed: 34223401
Lancet. 2021 Dec 4;398(10316):2093-2100
pubmed: 34756184
Lancet. 2020 Apr 16;:
pubmed: 32305074
Nat Commun. 2021 Nov 4;12(1):6379
pubmed: 34737312
JAMA. 2021 Jul 6;326(1):35-45
pubmed: 34037666
JAMA. 2021 Nov 23;326(20):2043-2054
pubmed: 34734975
Science. 2021 Dec 03;374(6572):1178-1180
pubmed: 34855503
JAMA Netw Open. 2021 Jun 1;4(6):e2111675
pubmed: 34061205
Nat Commun. 2021 Nov 26;12(1):6871
pubmed: 34836955
Clin Infect Dis. 2020 Jul 27;:
pubmed: 32716496
JAMA Intern Med. 2020 Dec 1;180(12):1612-1613
pubmed: 32780097
Nature. 2021 Dec;600(7888):197-199
pubmed: 34857948
Lancet Infect Dis. 2021 May;21(5):629-636
pubmed: 33545090
Nature. 2021 Aug;596(7871):175-176
pubmed: 34345038
Nat Commun. 2021 Oct 5;12(1):5820
pubmed: 34611158
N Engl J Med. 2021 Sep 30;385(14):1330-1332
pubmed: 34469645
Lancet. 2021 Jul 17;398(10296):213-222
pubmed: 34246358
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):14857-14863
pubmed: 32527856
Nat Med. 2021 Dec;27(12):2108-2110
pubmed: 34728830
JAMA Netw Open. 2021 Jun 1;4(6):e2110782
pubmed: 34061203
Lancet. 2021 Nov 13;398(10313):1799-1800
pubmed: 34756204
JAMA Netw Open. 2020 May 1;3(5):e209670
pubmed: 32432708
N Engl J Med. 2020 Oct 1;383(14):1296-1299
pubmed: 32589371
N Engl J Med. 2021 Nov 4;385(19):1761-1773
pubmed: 34525277
BMJ. 2021 Nov 17;375:e068302
pubmed: 34789505
Lancet Digit Health. 2021 Mar;3(3):e136-e137
pubmed: 33483278
Nat Med. 2020 May;26(5):676-680
pubmed: 32371934
N Engl J Med. 2021 Sep 23;385(13):1172-1183
pubmed: 34192426
Microb Biotechnol. 2022 Mar;15(3):721-737
pubmed: 34962710
MMWR Morb Mortal Wkly Rep. 2021 May 28;70(21):779-784
pubmed: 34043610
Ann Intern Med. 2021 Mar;174(3):335-343
pubmed: 33205991
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595
pubmed: 32571934
JAMA Netw Open. 2021 Jul 1;4(7):e2118830
pubmed: 34328505
Nat Commun. 2021 Jun 11;12(1):3560
pubmed: 34117244
Nature. 2021 Dec;600(7889):367-368
pubmed: 34880488
Matter. 2020 Sep 2;3(3):950-962
pubmed: 32838296
Nat Commun. 2021 Jun 18;12(1):3737
pubmed: 34145289
Lancet. 2022 Jan 8;399(10320):152-160
pubmed: 34741818
Trials. 2021 Mar 29;22(1):234
pubmed: 33781304
Science. 2022 Jan 21;375(6578):331-336
pubmed: 34735261
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49):
pubmed: 34857639
Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32293-32301
pubmed: 33273115
Lancet Infect Dis. 2020 Aug;20(8):875
pubmed: 32687807
N Engl J Med. 2021 Oct 7;385(15):1393-1400
pubmed: 34525275
N Engl J Med. 2022 Jan 6;386(1):35-46
pubmed: 34752019
Innovation (N Y). 2020 May 21;1(1):100006
pubmed: 33458717
N Engl J Med. 2021 Nov 4;385(19):1774-1785
pubmed: 34551225
Cell. 2020 Oct 1;183(1):169-184.e13
pubmed: 32931734
Lancet Infect Dis. 2022 Feb;22(2):152-153
pubmed: 34756187
JAMA. 2020 Aug 18;324(7):703-704
pubmed: 32663246
N Engl J Med. 2021 Dec 16;385(25):e90
pubmed: 34551224
JAMA Netw Open. 2020 Jun 1;3(6):e2012099
pubmed: 32539149
Nat Med. 2021 May;27(5):790-792
pubmed: 33782619
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
Extreme Mech Lett. 2020 Oct;40:100924
pubmed: 32835043
Lancet Infect Dis. 2021 Jun;21(6):793-802
pubmed: 33743847
JAMA Intern Med. 2021 Sep 1;181(9):1251-1253
pubmed: 34096988
Science. 2020 Jun 26;368(6498):1422-1424
pubmed: 32461212
Ann Am Thorac Soc. 2021 Mar;18(3):399-407
pubmed: 33196294
Lancet. 2021 Nov 13;398(10313):1825-1835
pubmed: 34717829
Science. 2020 Dec 18;370(6523):1395-1397
pubmed: 33335046
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
N Engl J Med. 2021 Sep 2;385(10):954-956
pubmed: 34289272
Microb Biotechnol. 2022 Jan;15(1):135-148
pubmed: 34788497
Lancet Infect Dis. 2021 Oct;21(10):1365-1372
pubmed: 34051886
Nat Med. 2021 Dec;27(12):2136-2143
pubmed: 34728831